Scholarships part of emerging workforce solutions partnership forged earlier this year Concorde Career Collegesand Imagen Dental Partnerstoday announced the three recipients of Imagen Dental Partners' $3,325 scholarships to students at Concorde's Garden Grove, San Bernardino, and San Diego campuses. This is the second round of scholarships Imagen has awarded to Concorde students and is part […]

Qualia Life Sciences has distinguished itself in the supplement market since 2015 through industry-leading research and development standards, recently winning the Nutrition Business Journal's 2025 Science & Innovation Award. Now, their esteemed science team has added DanPardi as their new Chief Health Officer. https://mma.prnewswire.com/media/2668647/Qualia_Life_Sceinces_Black_Registered_TM_Logo.jpg Dan Pardi holds a PhD in Neuroscience from Stanford University and

Report uncovers 3 truths reshaping marketing: Brands struggle to break through the noise, personal AI agents are the new gatekeepers, and technology consolidation is accelerating Cordial, the leader in messaging for enterprise retail marketing teams, releases “Brands Battle for Attention as AI Redefines the Funnel,” a comprehensive research report revealing that brands are not prepared

Xiao-I Corporation (NASDAQ: AIXI), a global leader in artificial intelligence solutions, today announced the renewal of its strategic partnership for the eighth consecutive year with a leading Chinese manufacturer and marketer of high-end kitchen appliances. This long-term collaboration underscores the critical role of Xiao-I's AI solutions in transforming customer service, sales, and after-sales support for

(NASDAQ:ARTL), Extends Patent Protection Through December 2041 ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related Anorexia SOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain,

(NASDAQ:BCDA), SUNNYVALE, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the second quarter of 2025 and filed its quarterly report on Form 10-Q for the three and six months ended June 30,

(NASDAQ:WRAP), MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP) (“Wrap” or the “Company”), a recognized innovator in public safety technology, today announced the full launch of WrapVision, its next-generation, all-in-one body-worn camera platform. WrapVision is fully compliant with the Trade Agreements Act (“TAA”) and is a North American-made solution engineered to

(NASDAQ:SONN), – Dr. Richard Kenney, Chief Medical Officer of Sonnet, discusses the recently announced expansion of its clinical study of patients with platinum-resistant ovarian cancer (PROC) (SB221) – Watch the “What This Means” video here PRINCETON, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company

Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13 GlobeNewswire August 11, 2025 Extends Patent Protection Through December 2041 ART27.13 is Currently under Evaluation in a Phase 2 Study for the Treatment of Cancer-Related Anorexia SOLANA BEACH, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE)

Sonnet Releases Virtual Investor “What This Means” Segment GlobeNewswire August 11, 2025 – Dr. Richard Kenney, Chief Medical Officer of Sonnet, discusses the recently announced expansion of its clinical study of patients with platinum-resistant ovarian cancer (PROC) (SB221) – Watch the “What This Means” video here PRINCETON, N.J., Aug. 11, 2025 (GLOBE NEWSWIRE) — Sonnet